Assays to detect pre-existing antibodies to adeno-associated virus (AAV) viral vectors
PMA Number: P250002 · 2025-07-24
Advertisement
Device Summary
Frequently Asked Questions
What is the Assays to detect pre-existing antibodies to adeno-associated virus (AAV) viral vectors?
Assays to detect pre-existing antibodies to adeno-associated virus (AAV) viral vectors is a medical device that received FDA 510(k) clearance on 2025-07-24. The listed applicant is Quest Diagnostics Nichols Institute.
When did Assays to detect pre-existing antibodies to adeno-associated virus (AAV) viral vectors receive FDA 510(k) clearance?
The clearance date for Assays to detect pre-existing antibodies to adeno-associated virus (AAV) viral vectors can be found in the official FDA records.
Who is the listed applicant for Assays to detect pre-existing antibodies to adeno-associated virus (AAV) viral vectors?
The FDA 510(k) record lists Quest Diagnostics Nichols Institute as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Assays to detect pre-existing antibodies to adeno-associated virus (AAV) viral vectors?
The FDA product code for Assays to detect pre-existing antibodies to adeno-associated virus (AAV) viral vectors is QWQ.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement